Olympus Endoscopes Now Powered by Next-Generation Ultrasound Processor
ProSound F75 Ultrasound Imaging Platform Enables More Accurate Diagnosis of
Cancers in GI Tract
CENTER VALLEY, Pa., May 14, 2013
CENTER VALLEY, Pa., May 14, 2013 /PRNewswire/ --Olympus, a precision
technology leader in designing and delivering innovative solutions in Medical
and Surgical Products, among other core businesses, announced today that the
Company's ultrasound endoscopes will now be powered by the ProSound F75
(Photo: http://photos.prnewswire.com/prnh/20130514/PH12497 )
The ProSound F75 Ultrasound Processor, developed in partnership by Hitachi
Aloka Medical, Ltd., provides physicians with the highest quality imaging—that
aids in more accurate diagnosis of diseases of the GI track and surrounding
organs such as the pancreas, bile duct, liver, spleen and gallbladder as well
as assessing a variety of cancers. The newly introduced platform improves
workflow from pre-examination to after examination for better data management,
and provides improved visualization for more accurate blood flow information.
"The ProSound F75 delivers outstanding image quality that facilitates easy
identification and more accurate staging of GI tumors in my practice," said
Dr. Shyam Varadarajulu, Medical Director of the Center for Interventional
Endoscopy (CIE) and Professor of Medicine at the University of Central
Florida. "The images are crisp with excellent resolution and the technology
is truly versatile in its functionality."
The ProSound F75 Ultrasound Processor offers a unique ergonomic capability
with an adjustable height and depth of the keyboard and monitor that provides
comfort to all endoscopists in a practice. The ProSound F75 has versatile
capabilities for conducting quick tasks and examinations in every clinical
setting. In addition, the device is forward and backward compatible which
allows it to work with most endoscopic ultrasound (EUS) and endobronchial
ultrasound (EBUS) scopes.
"We are very pleased to partner with Hitachi Aloka Medical, Ltd. and provide
our customers with a complete solution for imaging that addresses both their
clinical and operational needs," said Luke Calcraft, President of the Medical
Systems Group at Olympus Corporation of the Americas. "The ProSound F75
enables physicians to realize clinical efficacy through premier imaging and
helps healthcare facilities to achieve efficient asset management through
forward and backward scope compatibility of the platform."
Olympus is a pioneer of endoscopic ultrasound (EUS) which combines ultrasound
technology with endoscopy to better visualize the tissues of the digestive
tract and adjacent anatomical structures inside the human body. Conventional
ultrasound is performed by placing a transducer against the skin to produce
images of internal organs. With EUS, the transducer is endoscopically
inserted into the body via the digestive tract, putting it closer to the area
of interest to obtain higher resolution images.
This technology addresses the key requirements of Healthcare Reform:
oIncreased Quality of Care – EUS drives optimal patient outcomes through
easy identification and more accurate staging of diseases and cancers in
the GI tract.
oDecreased Costs – The forward and backward compatibility provides
significant cost savings through lower cost of ownership and more
efficient use of assets.
oEnhanced Patient Satisfaction – EUS provides a less invasive approach than
conventional surgical diagnosis allowing physicians to view internal
anatomy without making an incision
According to the American Cancer Society, there are more than 125,000 newly
diagnosed cases of gastrointestinal cancer each year in the United States with
more than 91,000 deaths from these diseases in 2013. In addition, Truven
Health estimates that the total number of EUS outpatient procedures will grow
15% from 2011 to 2016 and reach 235,000 procedures.
The ProSound F75 Ultrasound Processor will be showcased at the Digestive
Disease Week (DDW) 2013 Annual Meeting to be held May 18-21 in Orlando, FL.
Physicians are invited to visit booth #548 to further explore the benefits of
the new ultrasound imaging platform.
For more information or to evaluate the ProSound F75 Ultrasound Processor,
please contact your Olympus representative or call 800-848-9024.
About Olympus Medical Systems Group
Olympus Medical Systems Group, a division of global technology leader Olympus,
develops solutions for healthcare professionals that help improve clinical
outcomes, reduce overall costs and enhance quality of life for their patients.
By enabling less invasive procedures, innovative diagnostic and therapeutic
endoscopy, and early stage lung cancer evaluation and treatments, Olympus is
transforming the future of healthcare.
For more information visit Olympus at www.olympusamerica.com.
About Hitachi Aloka Medical, Ltd. (Subsidiary of Hitachi Medical Corporation)
Hitachi Aloka Medical, Ltd. is committed to delivering advanced diagnostic
ultrasound systems to meet the needs of physicians and patients. The company
was formed when Aloka Co., Ltd. became a 100% subsidiary of Hitachi Medical
Corporation on March 3, 2011 and changed its name to Hitachi Aloka Medical,
Ltd. on April 1, 2011. Aloka commercialized medical ultrasound equipment for
the first time in the world in 1960 and as Hitachi Aloka Medical, Ltd.
continues to promote the ultrasound business under its highly valued Aloka
brand. With its U.S. headquarters in Wallingford, CT, Hitachi Aloka Medical
America employs local sales, service and clinical applications professionals
across the nation. www.hitachi-aloka.com
SOURCE Olympus Corporation of the Americas
Contact: Michael Levey, Olympus Corporation of the Americas, 484-896-5120,
Press spacebar to pause and continue. Press esc to stop.